Poland· PL-100376883
Zepatier
A elbasvir and grazoprevir product containing elbasvirum + grazoprevirum, registered in Poland by Merck Sharp & Dohme B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Elbasvir and grazoprevir is registered in 11 of 19 countries.
Countries holding a registration under ATC J05AP54 (elbasvir and grazoprevir), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Elbasvir and grazoprevir · ATC J05AP54
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Elbasvirum + Grazoprevirum
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Poland (PL)
- ATC code
- J05AP54
- ATC class
- Elbasvir and grazoprevir
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05901549325102
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Elbasvir and grazoprevir in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaZEPATIERMerck Sharp & Dohme B.V., Haarlem
- United StatesZEPATIERMerck Sharp & Dohme LLC
- United KingdomZepatier 50mg/100mg tabletsMerck Sharp & Dohme (UK) Ltd
- SpainZEPATIER 50MG/100MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Sharp & Dohme B.V.
- FinlandZEPATIERMerck Sharp & Dohme B.V.
- FranceZEPATIER 50 mg/100 mg, comprimé pelliculéMERCK SHARP & DOHME (PAYS-BAS)
- IrelandZEPATIER 50 mg/100 mg film-coated tabletsMerck Sharp & Dohme BV,
- IcelandZepatierMerck Sharp & Dohme B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zepatier
- Liechtenstein · Zepatier
- Norway · Zepatier
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5494d77-afc8-4162-b96b-403eb79503a9 GET /v1/drugs/f5494d77-afc8-4162-b96b-403eb79503a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "50 mg + 100 mg",
"packaging": "05901549325102 ¦ Rpz ¦ EU/1/16/1119/001 ¦ 117618\n28 tabl.",
"substance": "Elbasvirum 50 mg + Grazoprevirum 100 mg",
"common_name": "Elbasvirum + Grazoprevirum",
"pl_product_id": "100376883",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about elbasvir and grazoprevir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.